Back to Search Start Over

Oculis sees promise in dry eye disease subgroup, plans phase 3.

Authors :
Taylor, Nick Paul
Source :
FierceBiotech; 6/10/2024, pN.PAG-N.PAG, 1p
Publication Year :
2024

Abstract

Oculis is advancing its precision medicine approach to dry eye disease, outlining plans to finalize a phase 3 study after seeing signs of efficacy. [ABSTRACT FROM AUTHOR]

Subjects

Subjects :
DRY eye syndromes
INDIVIDUALIZED medicine

Details

Language :
English
Database :
Complementary Index
Journal :
FierceBiotech
Publication Type :
Periodical
Accession number :
177802109

Tools

Authors Abstract Subjects Details